Healx is focused on accelerating the development of treatments for rare diseases. DrugBank is one of many data sources they integrate into their internal databases and knowledge graph. They use a wide range of data from DrugBank to train their drug repurposing algorithms, including drug properties, targets, indications, clinical trials and drug-drug interactions.
Read the full white paperMolecular Health is a transformational biomedical intelligence company with the mission of improving human health by liberating the power of clinical and molecular data. Molecular Health relies on DrugBank’s drug structure, classification, synonyms, drug-targets as well as drug-drug interactions.
Read the full white paperThe effects of COVID-19 have reverberated across the globe since late 2019, and have resulted in an influx of new research and data being produced on potential novel candidates to treat the virus. This paper will give an overview of COVID-19, ongoing research, and how data-driven drug repurposing using data from DrugBank is giving life to high-potential investigative treatments for this worldwide outbreak.
Read the full white papertwoXAR Pharmaceuticals is a drug discovery and development company focused on first-in-class small molecules. The company currently has a development portfolio of over 18 diseases. twoXAR saves years in drug development while generating a 30x hit rate at in vivo efficacy milestones over traditional methods.
Read the full white paperGenXys is a global leader in medication decision support and pharmacogenetic solutions. GenXys’ flagship digital prescribing assistant and medication review tools are used to enable optimized, personalized, and informed prescribing choices.
Read the full white paperThrive Health was founded to fundamentally improve the delivery of healthcare in Canada and around the world. Thrive Health uses DrugBank’s structured data to power their healthcare platforms, applications, and software tools aimed at improving healthcare delivery by engaging with patients.
Read the full white paper